Be part of the knowledge.™

The epidemic of end-stage renal disease

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
The number of patients with end-stage renal disease is growing rapidly. Dr. Michael Kraus, Nephrologist at Indiana University, reviews the statistics and ways to prevent ESRD in at-risk patients.

Michael Kraus, MD

Michael Kraus, MD

Matthew J. Sorrentino, MD, FACC, FASH

Matthew J. Sorrentino, MD, FACC, FASH

Recommended

Details

Presenters

Overview
The number of patients with end-stage renal disease is growing rapidly. Dr. Michael Kraus, Nephrologist at Indiana University, reviews the statistics and ways to prevent ESRD in at-risk patients.

Michael Kraus, MD

Michael Kraus, MD

Matthew J. Sorrentino, MD, FACC, FASH

Matthew J. Sorrentino, MD, FACC, FASH

Program Chapters

Segment Chapters

Playlist:

Recommended

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

$IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement$

IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement

Level Up Your Skills: Tailoring Management of HF

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids

Clinician's Roundtable

Challenges in AI-Driven Dermatology: Understanding Current Limitations

Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF

Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial

ACC Action Center

Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D